Tower Research Capital LLC (Trc) Opti Nose, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Opti Nose, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,274 shares of OPTN stock, worth $3,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,274
Previous 23,574
64.9%
Holding current value
$3,475
Previous $24,000
79.17%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding OPTN
# of Institutions
62Shares Held
88.3MCall Options Held
0Put Options Held
0-
Mvm Partners, LLC Boston, MA14.6MShares$6.13 Million10.4% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT14.4MShares$6.03 Million0.57% of portfolio
-
Great Point Partners LLC Greenwich, CT12.9MShares$5.4 Million3.98% of portfolio
-
Stonepine Capital Management, LLC Bend, OR5.69MShares$2.39 Million2.41% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY5.6MShares$2.35 Million0.45% of portfolio
About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $35M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...